These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9307284

  • 21. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T, Sasagawa T, Yamazaki H, Sakaike J, Ishikawa H, Inoue M.
    Cancer; 1999 May 01; 85(9):2001-10. PubMed ID: 10223242
    [Abstract] [Full Text] [Related]

  • 22. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
    Sima N, Kong DB, Wang W, Lu YP, Wang SX, Ma D.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 19; 87(23):1618-21. PubMed ID: 17803852
    [Abstract] [Full Text] [Related]

  • 23. Tumorigenicity of the E6 and E6-E7 gene constructions derived from human papillomavirus type 33.
    Kitasato H, Hillova J, Lenormand M, Hill M.
    Anticancer Res; 1991 Jun 19; 11(3):1165-72. PubMed ID: 1653554
    [Abstract] [Full Text] [Related]

  • 24. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
    Kunke D, Grimm D, Denger S, Kreuzer J, Delius H, Komitowski D, Kleinschmidt JA.
    Cancer Gene Ther; 2000 May 19; 7(5):766-77. PubMed ID: 10830724
    [Abstract] [Full Text] [Related]

  • 25. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM, Benítez-Hess ML, DiPaolo JA.
    Antivir Ther; 2003 Aug 19; 8(4):265-78. PubMed ID: 14518695
    [Abstract] [Full Text] [Related]

  • 26. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY.
    Reprod Sci; 2007 Jan 19; 14(1):20-8. PubMed ID: 17636212
    [Abstract] [Full Text] [Related]

  • 27. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Jonson AL, Rogers LM, Ramakrishnan S, Downs LS.
    Gynecol Oncol; 2008 Nov 19; 111(2):356-64. PubMed ID: 18755502
    [Abstract] [Full Text] [Related]

  • 28. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK, Cheng SC, Sin FW, Xie Y.
    Vaccine; 2004 Dec 16; 23(5):629-38. PubMed ID: 15542183
    [Abstract] [Full Text] [Related]

  • 29. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K, Dannenberg AJ.
    Cancer Res; 2007 Apr 15; 67(8):3976-85. PubMed ID: 17440114
    [Abstract] [Full Text] [Related]

  • 30. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
    Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS, Chen IS, Liu X.
    Oncogene; 2005 Jul 28; 24(32):5069-78. PubMed ID: 15856013
    [Abstract] [Full Text] [Related]

  • 31. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA.
    Khan MA, Canhoto AJ, Housley PR, Creek KE, Pirisi L.
    Exp Cell Res; 1997 Oct 10; 236(1):304-10. PubMed ID: 9344611
    [Abstract] [Full Text] [Related]

  • 32. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M, Milner J.
    Oncogene; 2002 Sep 05; 21(39):6041-8. PubMed ID: 12203116
    [Abstract] [Full Text] [Related]

  • 33. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E, Engin TS, Basaraba A, Coker AL, Creek KE, Pirisi L.
    Cancer Res; 2001 May 01; 61(9):3837-43. PubMed ID: 11325860
    [Abstract] [Full Text] [Related]

  • 34. Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.
    Daemen T, Pries F, Bungener L, Kraak M, Regts J, Wilschut J.
    Gene Ther; 2000 Nov 01; 7(21):1859-66. PubMed ID: 11110419
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of papilloma progression by antisense oligonucleotides targeted to HPV11 E6/E7 RNA.
    Clawson GA, Miranda GQ, Sivarajah A, Xin P, Pan W, Thiboutot D, Christensen ND.
    Gene Ther; 2004 Sep 01; 11(17):1331-41. PubMed ID: 15229628
    [Abstract] [Full Text] [Related]

  • 36. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.
    von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L.
    Cancer Res; 1988 Jul 01; 48(13):3780-6. PubMed ID: 2837324
    [Abstract] [Full Text] [Related]

  • 37. Ribozyme-mediated in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16.
    Lu D, Chatterjee S, Brar D, Wong KK.
    Cancer Gene Ther; 1994 Dec 01; 1(4):267-77. PubMed ID: 7627817
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M.
    Cancer Res; 1998 Feb 01; 58(3):549-55. PubMed ID: 9458104
    [Abstract] [Full Text] [Related]

  • 39. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
    Liu Z, Ghai J, Ostrow RS, Faras AJ.
    Virology; 1995 Feb 20; 207(1):260-70. PubMed ID: 7871737
    [Abstract] [Full Text] [Related]

  • 40. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS.
    Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.